港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

同源康醫藥-B

19.060

-0.640-3.25%

成交量：293.60萬

成交額：5,630.52萬

市值：70.71億

市盈率：-15.21

高：20.200

開：20.200

低：18.340

收：19.700

資料載入中...

總覽公司新聞公告

港股異動 | 同源康醫藥-B(02410)早盤一度漲超40% TY-9591關鍵II期臨牀試驗研究者數據顯示達到研究預期

深交所發佈關於深港通下的港股通標的證券名單調整的公告

深交所网站

同源康醫藥(02410)：TY-9591的關鍵II期臨牀試驗研究者數據顯示達到研究預期

智通港股早知道 | 港股今年日均成交額超2000億港元 3月組件排產提升顯著

【同源康醫藥-B(02410.HK)：TY-9591對比奧希替尼作為一線治療EGFR突變肺癌腦轉移的關鍵II期臨牀試驗研究者數據顯示達到研究預期，具有統計學顯著意義和重大臨牀獲益】同源康醫藥-B(02410.HK)公佈，公司自主研發的TY-9591(商品名：卡達沙®)對比奧希替尼(商品名：泰瑞沙®)作為一線治療EGFR突變肺癌腦轉移的關鍵 II期臨牀試驗根據研究者數據顯示具有統計學顯著意義和重大臨牀獲益。主要研究終點顱內客觀緩解率(iORR)達到預期目的，TY-9591對比奧希替尼顯示出統計學顯著意義和臨牀意義的明顯改善，無論在全人羣還是在不同亞組人羣(包括基因分型、顱內病灶個數、ECOG評分等)中均具有明顯統計學差異。

同源康醫藥-B(02410)：TY-9591對比奧希替尼作為一線治療EGFR突變肺癌腦轉移的關鍵II期臨牀試驗研究者數據顯示達到研究預期，具有統計學顯著意義和重大臨牀獲益

同源康醫藥-B03月07日獲主力加倉930萬元

同源康醫藥-B盤中異動臨近午盤股價大漲5.58%報31.200港元

同源康醫藥-B盤中異動下午盤股價大跌6.45%報29.000港元

同源康醫藥-B盤中異動早盤大幅下挫5.63%報30.200港元

同源康醫藥-B盤中異動快速跳水7.26%報30.000港元

同源康醫藥-B盤中異動早盤大幅跳水6.40%報28.500港元

同源康醫藥-B盤中異動早盤股價大漲5.27%報29.950港元

同源康醫藥-B盤中異動早盤股價大漲5.03%

同源康醫藥－Ｂ(02410)股價下跌9.239%，現價港幣$25.05

阿斯达克财经

同源康醫藥-B盤中異動急速拉昇5.43%

同源康醫藥-B盤中異動大幅跳水5.00%

同源康醫藥－Ｂ(02410)股價下跌5%，現價港幣$29.45

阿斯达克财经

【券商聚焦】中金對恒生與港股通調整影響分析：27支股份可能符合納入港股通條件

格隆匯個股放量排行榜 | 2月23日

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02410/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康醫藥-B","latestPrice":19.06,"timestamp":1752826115016,"preClose":19.7,"halted":0,"volume":2936000,"delay":0,"floatShares":366000000,"shares":371000000,"eps":-1.2528327344196415,"marketStatus":"已收盤","change":-0.64,"latestTime":"07-18 16:08:35","open":20.2,"high":20.2,"low":18.34,"amount":56305195,"amplitude":0.094416,"askPrice":19.08,"askSize":2500,"bidPrice":19.06,"bidSize":7500,"shortable":3,"etf":0,"ttmEps":-1.2528327344196415,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1753061400000},"marketStatusCode":5,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":19.7,"openAndCloseTimeList":[[1752802200000,1752811200000],[1752814800000,1752825600000]],"volumeRatio":1.532919,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":366000000,"roa":"-28.86%","roe":"--","lyrEps":-1.252833,"volumeRatio":1.532919,"shares":371000000,"dividePrice":0,"high":20.2,"amplitude":0.094416,"preClose":19.7,"low":18.34,"week52Low":12.86,"pbRate":"13.79","psRate":"60458.48","week52High":56.55,"institutionHeld":0,"latestPrice":19.06,"committee":0.5,"eps":-1.2528327344196415,"divideRate":0,"volume":2936000,"delay":0,"ttmEps":-1.2528327344196415,"open":20.2,"prevYearClose":47.15,"prevWeekClose":19.82,"prevMonthClose":21.7,"prevQuarterClose":21.7,"fiveDayClose":19.82,"twentyDayClose":16.18,"sixtyDayClose":28},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518255540","title":"港股異動 | 同源康醫藥-B(02410)早盤一度漲超40% TY-9591關鍵II期臨牀試驗研究者數據顯示達到研究預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2518255540","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518255540?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 09:34","pubTimestamp":1741570495,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B早盘一度涨超40%，截至发稿，涨36.93%，报41.9港元，成交额330万港元。消息面上，3月9日，同源康医药-B发布公告，公司自主研发的TY-9591对比奥希替尼作为一线治疗EGFR突变肺癌脑转移的关键II期临床试验根据研究者数据显示具有统计学显著意义和重大临床获益。公司计划于近期向国家药品监督管理局药品审评中心提交NDA上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1583","159938","03347","BK1515","02410","09939","BK1161","TY","BK1576","BK1141"],"gpt_icon":0},{"id":"2518258529","title":"深交所發佈關於深港通下的港股通標的證券名單調整的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2518258529","media":"深交所网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518258529?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 08:58","pubTimestamp":1741568314,"startTime":"0","endTime":"0","summary":"因恒生综合大型股指数、中型股指数、小型股指数实施成份股定期调整,根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发生调整并自2025年03月10日起生效，相关调整信息如下：","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310085053a269149e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310085053a269149e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02799","01942","03650","00095","01318","02570","02577","00743","02582","02407","01541","02150","09985","02431","06660","09959","02586","HSTECH","00410","02432","00041","01799","06698","03939","02510","03309","BK1240","BK1555","02587","00697","02678","09869","06623","01119","02506","02460","02507","03669","00659","02232","HSCEI","02487","02171","01600","00999","02562","01468","02105","BK1582","02410","02121","06639","02461","02411","02423","01268","09966","00308","02522"],"gpt_icon":0},{"id":"2518539642","title":"同源康醫藥(02410)：TY-9591的關鍵II期臨牀試驗研究者數據顯示達到研究預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2518539642","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518539642?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 08:54","pubTimestamp":1741568057,"startTime":"0","endTime":"0","summary":"金吾财讯 | 同源康医药 公告，公司自主研发的TY-9591对比奥希替尼作为一线治疗EGFR突变肺癌脑转移的关键II期临床试验根据研究者数据显示具有统计学显着意义和重大临床获益。主要研究终点颅内客观缓解率达到预期目的，TY-9591对比奥希替尼显示出统计学显着意义和临床意义的明显改善，无论在全人群还是在不同亚组人群中均具有明显统计学差异。公司计划于近期向国家药品监督管理局药品审评中心提交NDA 上市申请。","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/MTczNjE1NTkxMzE1OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/MTczNjE1NTkxMzE1OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954642","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1574","09939","BK1161","03347","BK1576","TY","BK1141","BK1583","159938","BK1515"],"gpt_icon":0},{"id":"2518923180","title":"智通港股早知道 | 港股今年日均成交額超2000億港元 3月組件排產提升顯著","url":"https://stock-news.laohu8.com/highlight/detail?id=2518923180","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518923180?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 06:59","pubTimestamp":1741561142,"startTime":"0","endTime":"0","summary":"陈翊庭：港股今年以来日均成交额超2000亿港元港交所行政总裁陈翊庭9日表示，港股今年以来日均成交额超2000亿港元。陈翊庭说，港股成交额在过去一年也有很大进步，由2023年平均每日成交额大约1000亿港元升至去年的1320亿港元，今年暂时已突破2000亿港元。她说，今年2月，港股每日成交金额有3次突破4000亿港元，其中很大部分来自世界各地的投资者。涉及港股 港交所及优质券商板块。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09969","HSCEI","BK1161","01208","YANG","BK1227","BK1592","BK1190","BK4614","02410","HSTECH","BK1574","BK1594"],"gpt_icon":1},{"id":"2518684402","title":"【同源康醫藥-B(02410.HK)：TY-9591對比奧希替尼作為一線治療EGFR突變肺癌腦轉移的關鍵II期臨牀試驗研究者數據顯示達到研究預期，具有統計學顯著意義和重大臨牀獲益】同源康醫藥-B(02410.HK)公佈，公司自主研發的TY-9591(商品名：卡達沙®)對比奧希替尼(商品名：泰瑞沙®)作為一線治療EGFR突變肺癌腦轉移的關鍵 II期臨牀試驗根據研究者數據顯示具有統計學顯著意義和重大臨牀獲益。主要研究終點顱內客觀緩解率(iORR)達到預期目的，TY-9591對比奧希替尼顯示出統計學顯著意義和臨牀意義的明顯改善，無論在全人羣還是在不同亞組人羣(包括基因分型、顱內病灶個數、ECOG評分等)中均具有明顯統計學差異。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518684402","media":"金融界","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518684402?lang=zh_tw&edition=fundamental","pubTime":"2025-03-09 19:12","pubTimestamp":1741518744,"startTime":"0","endTime":"0","summary":"同源康医药-B(02410.HK)公布，公司自主研发的TY-9591(商品名：卡达沙®)对比奥希替尼(商品名：泰瑞沙®)作为一线治疗EGFR突变肺癌脑转移的关键 II期临床试验根据研究者数据显示具有统计学显著意义和重大临床获益。主要研究终点颅内客观缓解率(iORR)达到预期目的，TY-9591对比奥希替尼显示出统计学显著意义和临床意义的明显改善，无论在全人群还是在不同亚组人群(包括基因分型、颅内病灶个数、ECOG评分等)中均具有明显统计学差异。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/09191248615055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK1583","TY","BK1574","03347","BK1515","02410","BK1576","BK1161","09939","159938"],"gpt_icon":0},{"id":"2518440289","title":"同源康醫藥-B(02410)：TY-9591對比奧希替尼作為一線治療EGFR突變肺癌腦轉移的關鍵II期臨牀試驗研究者數據顯示達到研究預期，具有統計學顯著意義和重大臨牀獲益","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440289","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518440289?lang=zh_tw&edition=fundamental","pubTime":"2025-03-09 19:07","pubTimestamp":1741518432,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)公布，公司自主研发的TY-9591(商品名：卡达沙®)对比奥希替尼(商品名：泰瑞沙®)作为一线治疗EGFR突变肺癌脑转移的关键 II期临床试验根据研究者数据显示具有统计学显著意义和重大临床获益。主要研究终点颅内客观缓解率(iORR)达到预期目的，TY-9591对比奥希替尼显示出统计学显著意义和临床意义的明显改善，无论在全人群还是在不同亚组人群(包括基因分型、颅内病灶个数、ECOG评分等)中均具有明显统计学差异。公司计划于近期向国家药品监督管理局药品审评中心(CDE)提交NDA (New Drug Application)上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02410","BK1583","TY","09939","159938","BK1161","BK1141","BK1576","03347","BK1515"],"gpt_icon":0},{"id":"2517095461","title":"同源康醫藥-B03月07日獲主力加倉930萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517095461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517095461?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 16:16","pubTimestamp":1741335402,"startTime":"0","endTime":"0","summary":"03月07日, 同源康医药-B股价涨3.55%，报收30.60元，成交金额2440万元，换手率0.22%，振幅15.40%，量比0.77。同源康医药-B今日主力资金净流入930万元，上一交易日主力净流入17万元。该股近5个交易日下跌5.41%，主力资金累计净流出419万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2522万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170707abecc8e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170707abecc8e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","09939","BK1574","BK1515"],"gpt_icon":0},{"id":"2517123724","title":"同源康醫藥-B盤中異動 臨近午盤股價大漲5.58%報31.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517123724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517123724?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 11:47","pubTimestamp":1741319271,"startTime":"0","endTime":"0","summary":"2025年03月07日临近午盘11时47分，同源康医药-B股票出现波动，股价急速上涨5.58%。截至发稿，该股报31.200港元/股，成交量26.25万股，换手率0.07%，振幅9.48%。资金方面，该股资金流入716.378万港元，流出64.575万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.48%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307114751989f5b70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307114751989f5b70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","BK1515","02410","BK1161"],"gpt_icon":0},{"id":"2517186478","title":"同源康醫藥-B盤中異動 下午盤股價大跌6.45%報29.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517186478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517186478?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 14:23","pubTimestamp":1741242194,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘14时23分，同源康医药-B股票出现波动，股价急速跳水6.45%。截至发稿，该股报29.000港元/股，成交量39.85万股，换手率0.11%，振幅9.52%。资金方面，该股资金流入665.168万港元，流出549.195万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.51%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306142314abeada0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306142314abeada0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","BK1515","02410","BK1574"],"gpt_icon":0},{"id":"2517093250","title":"同源康醫藥-B盤中異動 早盤大幅下挫5.63%報30.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517093250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517093250?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 09:42","pubTimestamp":1741138937,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时42分，同源康医药-B股票出现异动，股价急速下跌5.63%。截至发稿，该股报30.200港元/股，成交量2.85万股，换手率0.01%，振幅10.31%。资金方面，该股资金流入6.6225万港元，流出68.6275万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，康宁杰瑞制药-B、和誉-B、再鼎医药涨幅较大，振幅较大的相关个股有同源康医药-B、康宁杰瑞制药-B、和誉-B，振幅分别为9.38%、9.16%、8.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503050942179639f689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503050942179639f689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02410","09939","BK1161","BK1515"],"gpt_icon":0},{"id":"2516524270","title":"同源康醫藥-B盤中異動 快速跳水7.26%報30.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516524270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516524270?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 09:40","pubTimestamp":1740966028,"startTime":"0","endTime":"0","summary":"2025年03月03日早盘09时40分，同源康医药-B股票出现波动，股价快速跳水7.26%。截至发稿，该股报30.000港元/股，成交量8500股，换手率0.00%，振幅7.26%。资金方面，该股资金流入1.5425万港元，流出18.54万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，北海康成-B、圣诺医药-B、科济药业-B涨幅较大，振幅较大的相关个股有创胜集团-B、永泰生物-B、腾盛博药-B，振幅分别为12.24%、11.31%、8.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303094028abe53645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303094028abe53645&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","BK1515","02410","BK1574"],"gpt_icon":0},{"id":"2514369057","title":"同源康醫藥-B盤中異動 早盤大幅跳水6.40%報28.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514369057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514369057?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:48","pubTimestamp":1740707314,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘09时48分，同源康医药-B股票出现异动，股价快速跳水6.40%。截至发稿，该股报28.500港元/股，成交量1.25万股，换手率0.00%，振幅8.21%。资金方面，该股资金流入9.3万港元，流出28.1825万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为2.91%。其相关个股中，百济神州、正大企业国际、华昊中天医药-B涨幅较大，振幅较大的相关个股有科笛-B、腾盛博药-B、永泰生物-B，振幅分别为14.18%、12.44%、10.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228094834963340a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228094834963340a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","BK1515","02410","BK1161"],"gpt_icon":0},{"id":"2514816346","title":"同源康醫藥-B盤中異動 早盤股價大漲5.27%報29.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514816346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514816346?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 09:30","pubTimestamp":1740619821,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘09时30分，同源康医药-B股票出现异动，股价大幅拉升5.27%。截至发稿，该股报29.950港元/股，成交量500股，换手率0.00%，振幅0.00%。资金方面，该股资金流入1.4975万港元，流出0港元。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，同源康医药-B、腾盛博药-B、加科思-B涨幅较大，振幅较大的相关个股有腾盛博药-B、康诺亚-B、昭衍新药，振幅分别为5.96%、3.83%、3.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227093021a2558b09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227093021a2558b09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1515","02410","BK1161"],"gpt_icon":0},{"id":"2514078663","title":"同源康醫藥-B盤中異動 早盤股價大漲5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514078663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514078663?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 10:01","pubTimestamp":1740535312,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘10时01分，同源康医药-B股票出现波动，股价快速拉升5.03%。截至发稿，该股报25.050港元/股，成交量6.75万股，换手率0.02%，振幅5.24%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.63%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226100152abdd1ea4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226100152abdd1ea4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1574","BK1161","09939"],"gpt_icon":0},{"id":"2514911058","title":"同源康醫藥－Ｂ(02410)股價下跌9.239%，現價港幣$25.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2514911058","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514911058?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 14:30","pubTimestamp":1740465000,"startTime":"0","endTime":"0","summary":"[下跌股]同源康医药－Ｂ(02410) 股价在下午02:30比前收市价下跌9.239%，现股价为港币$25.05。至目前为止，今日最高价为$29.75，而最低价为$25.05。总成交量为38.65万股，总成交金额为港币$1.073千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2502252904/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","159938","BK1574","BK1161","02410","09939"],"gpt_icon":0},{"id":"2514080035","title":"同源康醫藥-B盤中異動 急速拉昇5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514080035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514080035?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 10:42","pubTimestamp":1740451366,"startTime":"0","endTime":"0","summary":"2025年02月25日早盘10时42分，同源康医药-B股票出现异动，股价急速拉升5.43%。截至发稿，该股报29.100港元/股，成交量5.55万股，换手率0.02%，振幅5.07%。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.06%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225104246a252b7bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225104246a252b7bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","02410","BK1161","09939"],"gpt_icon":0},{"id":"2513851794","title":"同源康醫藥-B盤中異動 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513851794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513851794?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 11:45","pubTimestamp":1740368732,"startTime":"0","endTime":"0","summary":"2025年02月24日临近午盘11时45分，同源康医药-B股票出现波动，股价快速跳水5.00%。截至发稿，该股报29.450港元/股，成交量13.05万股，换手率0.04%，振幅8.06%。同源康医药-B股票所在的生物技术行业中，整体跌幅为2.55%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022411453298904f1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022411453298904f1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1515","02410","BK1161"],"gpt_icon":0},{"id":"2513706791","title":"同源康醫藥－Ｂ(02410)股價下跌5%，現價港幣$29.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2513706791","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513706791?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 11:45","pubTimestamp":1740368700,"startTime":"0","endTime":"0","summary":"[下跌股]同源康医药－Ｂ(02410) 股价在上午11:45比前收市价下跌5%，现股价为港币$29.45。至目前为止，今日最高价为$31.95，而最低价为$29.45。总成交量为13.05万股，总成交金额为港币$399.518万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2502241996/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1574","02410","159938","BK1161","09939"],"gpt_icon":0},{"id":"2513767939","title":"【券商聚焦】中金對恒生與港股通調整影響分析：27支股份可能符合納入港股通條件","url":"https://stock-news.laohu8.com/highlight/detail?id=2513767939","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513767939?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:15","pubTimestamp":1740359737,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中金发研报指，2025年2月21日盘后，恒生指数公司公布了其定期的季度指数调整结果 。基于Bloomberg汇总，追踪恒生指数ETF资金规模约为314.9亿美元，追踪国企和恒生科技指数的ETF规模分别约为68.1亿美元和220.8亿美元。2) 恒生国企：被动资金流入所需时间最多的是本次被纳入的百济神州与中通快递，该行预计将带来8,850万与4,902万美元流入，流入时间分别约为2.7天与1.7天。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953706","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02232","BK1228","BK1521","BK1575","LU0370786039.SGD","BK1541","BK1610","LU2328871848.SGD","BK1109","06060","BK1191","LNNGY","BK1519","BK1512","00041","00697","BK1589","BK1516","IE00B29SXG58.USD","BK1583","BK1604","00308","BK1132","LU0072462343.USD","82331","HSTECH","02410","BK1128","BK1207","HSCEI","YANG","00999","BK1136","LU0823426480.USD","LU1969619763.USD","01797","BK1233","BK1596","LU0593848301.USD","LU0702159699.USD","01318","BK1216","LU1166156734.SGD","02331","01177"],"gpt_icon":1},{"id":"2513739837","title":"格隆匯個股放量排行榜 | 2月23日","url":"https://stock-news.laohu8.com/highlight/detail?id=2513739837","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513739837?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 17:30","pubTimestamp":1740303003,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日中创新航(03931)、开拓药业-B(09939)、首程控股(00697)、飞天云动(06610)、中国环境资源(01130)、先声药业(02096)、三叶草生物-B(02197)、药明康德(02359)、华润医疗(01515)、康龙化成(03759)、京信通信(02342)、山高控股(00412)、亚信科技(01675)、恒基地产(00012)、中国联通(0076","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/23173048332183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02105","00144","02246","02560","02878","00839","03833","01349","06680","02126","06881","01665","00400","09885","02100","02268","02440","00363","00412","02556","02567","00013","00867","00565","01815","02096","03382","01696","03698","00288","02678","06616","01616","09959","01769","00762","08071","00697","01675","06908","01093","00547","00340","00302","01268","02410","00696","02339"],"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":142,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1747411200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2025-07-17","current":-16.400555,"percent":0.892377,"low":-45.171338,"twenty":-26.231363,"median":-23.341814,"eighty":-17.914964,"high":-10.104382,"avg":-23.320866,"sd":6.573205,"marketCap":7305465614},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-17","current":-16.400555,"twenty":-26.231363,"median":-23.341814,"eighty":-17.914964,"marketCap":7305465614}],"updateTime":1752830185665}}}